Issues: Newer anti-diabetic therapies out of reach of >84% populations of Asia. Pharmaceuticals donot provide price discounts in resource-constrained-countries. incidence of insulin resistance neglected issue in resource-poor nations. Diabetes forums failed to address this concern. Hence we formed liaison study group of four clinics to analyse this issue and make policy paper. Resource poor nations have little technical expertise/manpower to study insulin resistance. Lack of resources for such research had demotivates young researchers.
Description: In developing countries cost-economics of diabetes treatment in rural/tribal India leads to poor-therapeutic-compliance. National/international programs donot offer discounted drugs, or diagnostics/technical assistance in diabetes-care. Insulin-resistance must be evaluated and corrective steps to minimise it. Health-care NGOs pivotal to facilitate development of sound/sustainable diabetes-care-programs. Its need of hour to organise specialised sessions on Insulin-resistance at ICE/ECE-congress for participants like us from Asian-countries.
Results/observations: There is need to provide technical/research skills from Industrialised-nations researchers to filter it to lesser privileged from developing nations like India. Currently no facility to learn/train on insulin-resistance. Major Lacunae is absence of system linking diabetes-caregivers from rural/tribal zones. Forums needed to implement/expand this suggestion/policy. Most of conferences address issues of cost/availability/ADRs BUT issues of drug-resistance neglected.
Recommendations: Development of tolls to tackle insulin-resistance is in infantile stage in developing-nations. Dialogue with western/European-researchers will accelerate policy implementation, increases resource and access to technical expertise. We need to break north-south barriers to counter resistance-issues. patient-advocates at ICE/ECE-2012 need to collaborate in future research-projects on this issue. We NGO-representatives from developing-nations need exposure to research technicalities/methodologies used by European/American experts. This is possible by our participation at Trondheim-meeting.
Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.
Funding: This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
05 - 09 May 2012
European Society of Endocrinology